The Highland Capital Management LLC Decreases Stake in Envision Healthcare Corporation (EVHC)

Claudine Rigal
Августа 13, 2017

LLC's holdings in Envision Healthcare Corporation were worth $572,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the company. Macquarie Group Ltd. boosted its position in shares of Envision Healthcare Corporation by 1,075.0% in the fourth quarter. Vanguard Group Inc. now owns 11,266,818 shares of the company's stock worth $690,881,000 after buying an additional 433,593 shares in the last quarter. Hexavest Inc. acquired a new position in Envision Healthcare Corporation during the first quarter worth approximately $41,197,000. BlackRock Inc. now owns 7,197,631 shares of the company's stock valued at $441,359,000 after buying an additional 7,017,467 shares during the last quarter. BlackRock Inc. raised its position in Envision Healthcare Corporation by 3,895.0% in the first quarter. Janus Capital Management LLC now owns 2,712,066 shares of the company's stock valued at $167,536,000 after buying an additional 1,055,014 shares during the last quarter. First Interstate Bank acquired a new position in shares of Envision Healthcare Corporation during the first quarter worth about $184,000. State Street Corp raised its position in Envision Healthcare by 4.1% in the first quarter. Atria Investments LLC now owns 5,380 shares of the company's stock worth $330,000 after buying an additional 1,282 shares in the last quarter. The institutional investor owned 3,723 shares of the company's stock after selling 1,657 shares during the period.

Shares of Envision Healthcare Corporation (NYSE:EVHC) traded up 0.23% during mid-day trading on Friday, hitting $52.89. The company had a trading volume of 456,695 shares. The stock's market capitalization is $6.19 billion. Envision Healthcare Corporation has a one year low of $51.44 and a one year high of $74.75. The stock has a 50 day moving average of $59.31 and a 200-day moving average of $61.09.

Envision Healthcare Corporation (NYSE:EVHC) last posted its quarterly earnings results on Monday, August 7th. The company reported $0.79 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.75 by $0.04. The company had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The company's revenue for the quarter was up 156.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.34 EPS. Equities research analysts expect that Envision Healthcare Corporation will post $1.40 EPS for the current fiscal year. If you are accessing this piece of content on another domain, it was stolen and republished in violation of USA and global copyright and trademark law. If you are accessing this report on another site, it was stolen and reposted in violation of United States and global trademark & copyright law. The correct version of this article can be viewed at https://www.chaffeybreeze.com/2017/08/13/envision-healthcare-corporation-nyseevhc-given-new-57-00-price-target-at-mizuho.html.

Several equities analysts recently issued reports on EVHC shares. Finally, Canaccord Genuity reissued a "buy" rating and set a $86.00 price target on shares of Envision Healthcare Corporation in a research note on Tuesday, April 18th. BidaskClub cut shares of Envision Healthcare Corporation from a "hold" rating to a "sell" rating in a research report on Tuesday, August 1st. Zacks Investment Research upgraded Envision Healthcare Corporation from a sell rating to a hold rating in a research report on Tuesday, May 2nd. Royal Bank Of Canada reiterated a "buy" rating and set a $72.00 price objective on shares of Envision Healthcare Corporation in a report on Wednesday, May 3rd.

TRADEMARK VIOLATION NOTICE: "Envision Healthcare Corporation (NYSE:EVHC) Given New $57.00 Price Target at Mizuho" was first reported by Chaffey Breeze and is the property of of Chaffey Breeze. The stock has a consensus rating of "Buy" and an average target price of $71.56.

In related news, insider Robert Jon Coward sold 1,500 shares of the firm's stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $60.00, for a total transaction of $90,000.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Wellington Management Group LLP now owns 9,512,290 shares of the company's stock valued at $583,294,000 after buying an additional 108,389 shares during the last quarter.

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. Envision, through its subsidiaries, provides various healthcare services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR).

According to the complaint, Envision touted EmCare's capabilities in its public filings, stating, "We believe that EmCare is well-positioned to continue to generate significant organic growth due to its integrated service offerings, differentiated, data-driven processes to recruit and retain physicians, scalable technology and sophisticated risk management programs".

D'autres rapports

Discuter de cet article